HealthStream Inc (HSTM)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at HealthStream Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 14.3% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- 0.17 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.16 | 6.00 | 74 | 5.20 | 6.60 | 11 | 11 |
| 2025: Q1 | 0.14 | -17.60 | 74 | 1.00 | 5.90 | 27 | 26 |
| 2025: Q2 | 0.18 | 29.60 | 74 | 4.00 | 7.20 | 5 | 3 |
| 2025: Q3 | 0.20 | 9.10 | 77 | 4.60 | 8.00 | 18 | 18 |
| 2025: Q4 | 0.09 | -46.60 | 80 | 7.40 | 3.20 | 13 | 13 |
| 2026: Q1 | 0.20 | 41.80 | 81 | 10.50 | 7.30 | 27 | 26 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
HealthStream, Inc. bietet Software-as-a-Service-(SaaS)-basierte Anwendungen für Gesundheitsorganisationen in den USA an.
| Employees | 1,139 |
|---|---|
| Headquarters | Nashville, TN |
| Website | healthstream.com |
| IPO Date | 5. Apr 2000 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Robert A. Frist Jr. | Co-Founder, Chairman of the Board & CEO | 1967 |
| Scott Alexander Roberts CPA | CFO and Senior VP of Accounting & Finance | 1977 |
| Michael M. Collier J.D. | Executive VP & COO | 1976 |
| Kevin P. O'Hara J.D. | Executive Vice President of Workforce Platform and Applications | 1970 |
| Trisha L. Coady B.S.N., R.N. | Executive Vice President of Workforce Development Solutions | 1976 |
| Jeffrey D. Cunningham | Senior VP & CTO | 1967 |
| Mollie Condra Ph.D. | Vice President of Investor Relations & Communications | – |
| Sneha Oakley | VP, Compliance Officer & General Counsel | – |
| Jennifer H. LoPresto | Senior Vice President of Sales | 1973 |
| Michael Scott McQuigg | Senior Vice President of Digital & Network Development | 1968 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.